ARCHIVES

Gynecologic Oncology Group To Conduct Phase III Trial of Xyotax For Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 4 | April 30, 2004

Download PDF Visit The Full Archive

Related Articles

NCAB Cancer Centers committee recommends Ratio Cap To Limit Growth of Largest Grants

February 14, 1992

Symposium to Focus on New Approaches to Drug Resistance

May 11, 1990

Cancer Letter On Vacation

August 3, 1984

Hammond Resigns As Director Of USC Comp Center

May 29, 1981

Abbott Seeks Applicants For Young Investigators Awards Program

January 4, 1991

Construction, Senior Biomedical Service Not In Legislation

November 4, 1988